Exenatide Once Weekly vs. Liraglutide Daily for Type 2 Diabetes
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
Background
Despite lifestyle modifications and existing oral antidiabetic medications, many patients with Type 2 Diabetes Mellitus struggle to achieve optimal glycemic control. GLP-1 receptor agonists are a highly effective class of treatments for this chronic metabolic condition, offering benefits beyond blood glucose reduction. However, there has been a significant knowledge gap regarding direct, head-to-head comparisons between exenatide once weekly and liraglutide once daily, making it challenging for clinicians to choose the most appropriate therapy for their patients.
TitrateLab articles covering Liraglutide
Written by TitrateLab, separately from the study summarized above.
